Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(7-carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-(7-carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide is an experimental small molecule compound belonging to the class of naphthalene derivatives. It has been structurally characterized and is known to bind to coagulation factor XI (FXI), a serine protease involved in the intrinsic pathway of blood coagulation. Structural studies have shown this compound as a ligand in complex with the catalytic domain of human factor XI, suggesting its role as an inhibitor of this target[6]. The primary research interest for this molecule is as a potential anticoagulant through inhibition of factor XIa activity. There are no approved indications or clinical development programs reported for this compound; it remains at the experimental stage[1][6].
- Other names
- N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDEDB07212DB-07212DB 07212
02
Targets
F11 (Coagulation Factor XI)
Beyond the preview
Go deeper on N-(7-carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(7-carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide.